Chemed Corp. (NYSE:CHE) VP Naomi C. Dallob sold 950 shares of the firm’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $240.38, for a total transaction of $228,361.00. Following the completion of the transaction, the vice president now directly owns 9,747 shares in the company, valued at approximately $2,342,983.86. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Chemed Corp. (CHE) opened at $245.45 on Thursday. Chemed Corp. has a 1 year low of $148.19 and a 1 year high of $245.90. The firm has a market cap of $3,862.81, a PE ratio of 29.80, a P/E/G ratio of 5.12 and a beta of 1.14. The company has a debt-to-equity ratio of 0.15, a current ratio of 0.50 and a quick ratio of 0.48.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Thursday, October 26th. The company reported $2.15 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.00 by $0.15. Chemed had a net margin of 4.62% and a return on equity of 27.69%. The business had revenue of $417.40 million for the quarter, compared to analysts’ expectations of $414.34 million. During the same quarter last year, the firm earned $1.73 EPS. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. equities analysts expect that Chemed Corp. will post 4.73 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, December 4th. Shareholders of record on Monday, November 13th will be given a dividend of $0.28 per share. The ex-dividend date is Friday, November 10th. This represents a $1.12 annualized dividend and a dividend yield of 0.46%. Chemed’s dividend payout ratio is currently 24.89%.

Institutional investors have recently bought and sold shares of the business. APG Asset Management N.V. bought a new position in shares of Chemed during the 3rd quarter worth approximately $5,657,000. Chicago Equity Partners LLC lifted its position in shares of Chemed by 88.5% during the 2nd quarter. Chicago Equity Partners LLC now owns 17,530 shares of the company’s stock worth $3,585,000 after buying an additional 8,230 shares in the last quarter. American Century Companies Inc. bought a new position in shares of Chemed during the 2nd quarter worth approximately $4,201,000. Strs Ohio lifted its position in shares of Chemed by 5.6% during the 2nd quarter. Strs Ohio now owns 1,900 shares of the company’s stock worth $388,000 after buying an additional 100 shares in the last quarter. Finally, Pinebridge Investments L.P. lifted its position in shares of Chemed by 66.6% during the 2nd quarter. Pinebridge Investments L.P. now owns 3,544 shares of the company’s stock worth $725,000 after buying an additional 1,417 shares in the last quarter. 97.72% of the stock is currently owned by hedge funds and other institutional investors.

CHE has been the topic of several recent research reports. TheStreet raised shares of Chemed from a “c+” rating to an “a-” rating in a research report on Friday, October 27th. Zacks Investment Research raised shares of Chemed from a “hold” rating to a “buy” rating and set a $213.00 price target on the stock in a research report on Wednesday, August 23rd. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $209.00 price target on shares of Chemed in a research report on Friday, September 1st. KeyCorp reaffirmed a “hold” rating on shares of Chemed in a research report on Friday, October 27th. Finally, BidaskClub cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Wednesday, August 2nd. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $236.00.

COPYRIGHT VIOLATION WARNING: This article was posted by Daily Political and is the property of of Daily Political. If you are reading this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright law. The original version of this article can be viewed at https://www.dailypolitical.com/2017/11/30/insider-selling-chemed-corp-che-vp-sells-228361-00-in-stock.html.

About Chemed

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.